(1)
DESIGN AND IN VIVO EVALUATION OF CONTROLLED RELEASE GLICLAZIDE TRILAYER MATRIX TABLETS IN THE MANAGEMENT OF DIABETES MELLITUS. Int. J. Pharm. Sci. Drug Res. 2018, 10 (5), 410-417. https://doi.org/10.25004/IJPSDR.2018.100508.